Obesity exacerbates MAFLD and osteoporosis by causing chronic low-grade inflammation in the liver (47), increasing insulin resistance (48), affecting leptin and lipocalin secretion (49, 50), and disrupting intestinal microcirculation (51, 52). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.